Browsing by Author Kostapanos, M. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 34  next >
TitleAuthor(s)Issue date
A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemiaKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Nakou, E. S.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjectsKostapanos, M. S.; Christogiannis, L. G.; Bika, E.; Bairaktari, E. T.; Goudevenos, J. A.; Elisaf, M. S.; Milionis, H. J.24-Nov-2015
The association between Type D personality and the metabolic syndrome: a cross-sectional study in a University-based outpatient lipid clinicTziallas, D.; Kostapanos, M. S.; Skapinakis, P.; Milionis, H. J.; Athanasiou, T.; S. Elisaf M; Mavreas, V.24-Nov-2015
Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemiaKostapanos, M. S.; Milionis, H. J.; Lagos, K. G.; Rizos, C. B.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Clopidogrel vs. aspirin treatment on admission improves 5-year survival after a first-ever acute ischemic stroke. data from the Athens Stroke Outcome ProjectMilionis, H. J.; Gerotziafas, G.; Kostapanos, M. S.; Vemmou, A.; Zis, P.; Spengos, K.; Elisaf, M. S.; Vemmos, K. N.24-Nov-2015
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistanceMoutzouri, E.; Liberopoulos, E.; Mikhailidis, D. P.; Kostapanos, M. S.; Kei, A. A.; Milionis, H.; Elisaf, M. S.24-Nov-2015
Current role of statins in the treatment of essential hypertensionKostapanos, M. S.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015
Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjectsMilionis, H. J.; Kostapanos, M. S.; Liberopoulos, E. N.; Goudevenos, J.; Athyros, V. G.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertensionChristogiannis, L. G.; Kostapanos, M. S.; Tellis, C. C.; Milionis, H. J.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Do statins beneficially or adversely affect glucose homeostasis?Kostapanos, M. S.; Liamis, G. L.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015
Do statins have an antiarrhythmic activity?Kostapanos, M. S.; Liberopoulos, E. N.; Goudevenos, J. A.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary HyperlipidemiaKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Christogiannis, L. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Dose-dependent effect of rosuvastatin treatment on urinary protein excretionKostapanos, M. S.; Milionis, H. J.; Saougos, V. G.; Lagos, K. G.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015
Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?Kostapanos, M. S.; Katsiki, N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015
Effect of Ezetimibe on Markers of Oxidative Stress in Patients with HypercholesterolemiaKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaKostapanos, M. S.; Derdemezis, C. S.; Filippatos, T. D.; Milionis, H. J.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
EFFECT OF STANDARD COMBINATION OF VALSARTAN WITH EITHER AMLODIPINE OR HYDROCHLOROTHIAZIDE ON LDL SUBFRACTION PROFILE IN PATIENTS WITH HYPERTENSIONChristogiannis, L. G.; Kostapanos, M. S.; Milionis, H. J.; Mitrogianni, Z.; Moutzouri, E.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome PatientsFilippatos, T. D.; Kostapanos, M. S.; Kostara, C.; Nakou, E. S.; Georgoula, M.; Derdemezis, C. S.; Kiortsis, D. N.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective studyRizos, C. V.; Milionis, H. J.; Kostapanos, M. S.; Florentin, M.; Kostara, C. E.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015
Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemiaFlorentin, M.; Kostapanos, M. S.; Nakou, E. S.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015